###begin article-title 0
###xml 95 96 95 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
B cell antigen receptor signal strength and peripheral B cell development are regulated by a 9-O-acetyl sialic acid esterase
###end article-title 0
###begin p 1
###xml 28 56 28 56 <email xmlns:xlink="http://www.w3.org/1999/xlink">pillai@helix.mgh.harvard.edu</email>
CORRESPONDENCE Shiv Pillai: pillai@helix.mgh.harvard.edu
###end p 1
###begin p 2
This article is distributed under the terms of an Attribution-Noncommercial-Share Alike-No Mirror Sites license for the first six months after the publication date (see ). After six months it is available under a Creative Commons License (Attribution-Noncommercial-Share Alike 3.0 Unported license, as described at ).
###end p 2
###begin p 3
###xml 189 190 189 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 509 510 505 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 157 161 <span type="species:ncbi:10090">Mice</span>
We show that the enzymatic acetylation and deacetylation of a cell surface carbohydrate controls B cell development, signaling, and immunological tolerance. Mice with a mutation in sialate:O-acetyl esterase, an enzyme that specifically removes acetyl moieties from the 9-OH position of alpha2-6-linked sialic acid, exhibit enhanced B cell receptor (BCR) activation, defects in peripheral B cell development, and spontaneously develop antichromatin autoantibodies and glomerular immune complex deposits. The 9-O-acetylation state of sialic acid regulates the function of CD22, a Siglec that functions in vivo as an inhibitor of BCR signaling. These results describe a novel catalytic regulator of B cell signaling and underscore the crucial role of inhibitory signaling in the maintenance of immunological tolerance in the B lineage.
###end p 3
###begin p 4
Abbreviations used: BCR, B cell receptor; CMAH, CMP-Neu-5Ac hydroxylase; ES, embryonic stem; ITIM, immunoreceptor tyrosine-based inhibitory motif; MZ, marginal zone; MZP, marginal zone B cell precursor; Siae: sialic acid acetyl esterase.
###end p 4
###begin p 5
H. Takematsu's present address is Laboratory of Membrane Biochemistry and Biophysics, Graduate School of Biostudies, Kyoto University, Kyoto 606-8501, Japan.
###end p 5
###begin p 6
###xml 229 230 229 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 232 233 232 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib2">2</xref>
###xml 301 302 301 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 634 637 634 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink">-O-</italic>
###xml 743 744 743 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 762 763 762 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
###xml 765 766 765 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 922 923 922 923 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 1018 1019 1018 1019 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
###xml 1096 1097 1096 1097 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 1179 1180 1179 1180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 1199 1200 1199 1200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 545 564 <span type="species:ncbi:11552">influenza C viruses</span>
###xml 1012 1016 <span type="species:ncbi:10090">mice</span>
###xml 1141 1147 <span type="species:ncbi:10090">murine</span>
Sialic acids are a diverse family of acidic sugars with a shared nine-carbon backbone. They participate in numerous cell-cell recognition events and can also mediate the binding to vertebrate cells of certain toxins and viruses (1, 2). A relatively common postsynthetic modification of sialic acid is O-acetylation at the C-9 position. Acetylation of sialic acid also frequently occurs at the C-7 position, from where the acetyl group can spontaneously migrate to the 9-OH position under physiological conditions. The hemagglutinin esterases of influenza C viruses and certain nidoviruses, including group 2 coronaviruses, recognize 9-O-acetylated sialic acid-containing glycoconjugates on the surface of host cells, and some can remove the 9-O-acetyl moieties (3, 4). However, the in vivo biological function of this acetylation event has remained a mystery. One attempt to elucidate the biological role of sialic acid 9-O-acetylation involved the transgenic expression of Influenza C hemagglutinin esterase in mice (5). This led to a defect in early embryogenesis, indirectly suggesting that 9-O-acetyl sialic acid may be essential during murine development. In vitro studies (6) suggested that 9-O-acetylation of alpha2-6-linked sialic acid containing glycoconjugates impairs the recognition of this glycan moiety by certain Siglecs (sialic acid binding Ig superfamily lectins) including CD22. However, despite these and other tantalizing clues, the intrinsic in vivo functions of this abundant modification have not been established.
###end p 6
###begin p 7
###xml 325 326 325 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 327 328 327 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
###xml 447 449 443 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 451 453 447 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 637 639 633 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 986 988 982 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 989 991 985 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 1461 1463 1457 1459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 1464 1466 1460 1462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 1571 1572 1563 1564 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 1813 1814 1805 1806 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 1848 1849 1840 1841 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 2187 2189 2171 2173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 2283 2285 2267 2269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">26</xref>
###xml 137 143 <span type="species:ncbi:9606">humans</span>
###xml 980 984 <span type="species:ncbi:10090">mice</span>
The Siglecs are the largest known group of vertebrate sialic acid-recognizing cell surface proteins. This family comprises 13 members in humans including sialoadhesin (Siglec-1), CD22 (Siglec-2), CD33 (Siglec-3), myelin associated glycoprotein (Siglec-4), Siglec-15, and the so-called CD33-related Siglecs, 5-10, 11, and 14 (7-9). CD22 is one of the best studied Siglecs and binds specifically to alpha2-6-linked sialic acid-containing N-glycans (10, 11). CD22 inhibitory signaling depends on the recruitment of SHP-1 to phosphorylated tyrosine residues in immunoreceptor tyrosine-based inhibitory motifs (ITIM) in its cytoplasmic tail (12). Antigen receptor cross-linking leads to the activation of Lyn and other less abundant Src-family kinases that phosphorylate ITIM tyrosines in CD22. Initiation of inhibitory signaling by CD22 is not well understood and the exact mechanism remains controversial. The simplest model that may be indirectly inferred from the phenotypes of KO mice (13-20) suggests that antigen receptor ligation contributes to the sialic acid-dependent recruitment of CD22 to the BCR and the subsequent phosphorylation by Lyn of CD22 ITIM tyrosines, which is followed by the recruitment and activation of SHP-1. Other mechanisms of signal initiation have been suggested by several studies variously implicating sialic acid-dependent homooligomerization and sialic acid-independent association of this Siglec with the B cell receptor (BCR) (21-24). Because CD22 is expressed constitutively on mature B cells and alpha2-6-linked sialic acid-containing N-glycans are abundantly present on the cell surface, it could be argued that CD22 inhibition may itself be constitutive. How inhibitory signaling via CD22 is temporally regulated in mature B cells is unclear. Because CD22 does not bind to 9-O-acetylated sialic acid in vitro (6), we considered the possibility that the function of this Siglec might be regulated in vivo by the enzymatic acetylation and deacetylation of alpha2-6-linked sialic acid. Sialic acid acetyl esterase (Siae), which is molecularly characterized as an enzyme that removes acetyl groups from the 9-OH position of alpha2-6-linked sialic acid (25), was also independently identified as a gene that is up-regulated during B cell maturation (26), suggesting a role in the biology of B lymphocytes. In this paper, we show that Siae influences B cell signaling and B cell development and participates in inhibitory signaling mechanisms that are crucial to the maintenance of immunological tolerance in the B lineage.
###end p 7
###begin title 8
RESULTS
###end title 8
###begin title 9
###xml 8 9 8 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
Sialate O-acetylesterase is secreted and can access the cell surface
###end title 9
###begin p 10
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 15 40 15 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">sialate:O-acetyl esterase</italic>
###xml 327 329 327 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 330 332 330 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">27</xref>
###xml 751 752 751 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 930 936 <span type="species:ncbi:10090">murine</span>
###xml 1007 1013 <span type="species:ncbi:10090">murine</span>
The Siae gene (sialate:O-acetyl esterase) can generate two alternatively spliced variants. One form contains a signal peptide and can encode a protein that enters the secretory pathway (originally called Lse [lysosomal sialic acid acetylesterase]), whereas the other lacks this signal peptide and encodes a cytosolic esterase (25-27). Although the Lse protein was thought to localize to lysosomes, a site that would not be suitable for the modification of Siglec ligands, we have observed in transfected cells that this protein exhibits, at best, a limited lysosomal localization and is secreted and can bind to the surface of transfected cells (Figs. S1 and S2, available at ). The enzyme, therefore, has the potential to remove acetyl groups from 9-O-acetylated Siglec ligands in a post Golgi vesicle or at the cell surface. Although some antibodies against Siae have been generated, they lack the specificity to detect Siae in murine cells and tissue sections. The actual location of the Siae protein in murine B cells is therefore yet to be conclusively established.
###end p 10
###begin title 11
###xml 14 18 14 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 18 31 18 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;2/&#916;2</sup>
###xml 32 36 <span type="species:ncbi:10090">mice</span>
Generation of SiaeDelta2/Delta2 mice
###end title 11
###begin p 12
###xml 14 18 14 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 37 40 37 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lse</italic>
###xml 96 99 96 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lse</italic>
###xml 171 179 171 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 A</xref>
###xml 265 273 265 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 B</xref>
###xml 399 403 399 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 570 574 570 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 574 587 574 579 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;2/&#916;2</sup>
###xml 89 95 <span type="species:ncbi:10090">murine</span>
###xml 323 327 <span type="species:ncbi:10090">mice</span>
###xml 433 437 <span type="species:ncbi:10090">mice</span>
###xml 532 536 <span type="species:ncbi:10090">mice</span>
###xml 588 592 <span type="species:ncbi:10090">mice</span>
Exon 2 of the Siae gene is unique to Lse. An engineered in-frame deletion of exon 2 in a murine Lse complementary DNA resulted in a protein that lacked esterase activity (Fig. 1 A). Genomic deletion of exon 2 was achieved as described in the Materials and methods (Fig. 1 B). After germline transmission, homozygous mutant mice were generated and were found to be viable. Truncated exon 2-deficient Siae mRNA could be detected in KO mice (Fig. S3, available at ). Cytosolic esterase mRNA continues to be transcribed in these mutant mice. We refer to these KO animals as SiaeDelta2/Delta2 mice.
###end p 12
###begin p 13
###xml 38 42 38 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 0 77 0 77 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Targeted deletion of exon 2 of murine <italic>Siae</italic> results in enhanced BCR signaling.</bold>
###xml 193 197 193 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 226 229 226 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lse</italic>
###xml 640 641 640 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 739 741 739 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 903 907 903 907 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 31 37 <span type="species:ncbi:10090">murine</span>
###xml 186 192 <span type="species:ncbi:10090">murine</span>
###xml 814 820 <span type="species:ncbi:10090">murine</span>
###xml 1227 1232 <span type="species:ncbi:10090">mouse</span>
###xml 1268 1272 <span type="species:ncbi:10090">mice</span>
Targeted deletion of exon 2 of murine Siae results in enhanced BCR signaling. (A) Deletion of exon 2 abrogates the esterase activity of the Lse form of Siae. A WT C-terminal FLAG-tagged murine Siae expression construct of the Lse form and an exon 2-deleted version of this complementary DNA were transfected into COS7 cells. Cell culture medium was recovered and the recombinant protein purified by an antibody column directed to the FLAG epitope. Western blotting analysis on eluate fractions showed that both proteins were expressed, bound, and eluted from the column. Column eluate fractions were subjected to an assay for sialic acid 9-O-acetylesterase activity (left) and acetyl-CoA esterase activity (right) as previously described (25). Y axes show cpm. (B) Targeting strategy for the deletion of exon 2 of murine Siae. The top shows the targeting construct used to specifically target exon 2 of Siae. The middle shows the expected structure of the locus after targeting. The bottom left shows Southern Blotting of embryonic stem (ES) cells at each step of manipulation detected by a loxP-specific probe. The black line indicates that intervening lanes have been spliced out. The bottom right shows Southern blotting of mouse tail DNA after mating heterozygous mice that also expressed the ZP3-Cre Transgene. The expected deleted fragment is 6.5 kb and the expected WT fragment is 4.2 kb.
###end p 13
###begin title 14
###xml 52 56 52 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 56 69 56 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;2/&#916;2</sup>
###xml 70 74 <span type="species:ncbi:10090">mice</span>
Enhanced B lymphocyte antigen receptor signaling in SiaeDelta2/Delta2 mice
###end title 14
###begin p 15
###xml 43 44 43 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 257 259 253 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 260 262 256 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 354 358 350 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 358 371 354 359 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;2/&#916;2</sup>
###xml 508 514 496 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 152 156 <span type="species:ncbi:10090">mice</span>
###xml 251 255 <span type="species:ncbi:10090">mice</span>
###xml 265 269 <span type="species:ncbi:10090">Mice</span>
###xml 372 376 <span type="species:ncbi:10090">mice</span>
###xml 663 667 <span type="species:ncbi:10090">mice</span>
Because Siae has the potential to remove 9-O-acetyl residues from alpha2-6-linked sialic acid containing Siglec ligands, we predicted that B cells from mice lacking this esterase might exhibit enhanced BCR signaling similar to that noted in CD22-null mice (13-16). Mice were first bred into the C57BL/6 background for 10 generations. B cells from WT and SiaeDelta2/Delta2 mice were gated on, and the accumulation of cytoplasmic calcium after ligation of the BCR was analyzed using flow cytometry. As seen in Fig. 2, BCR cross-linking resulted in an accelerated and enhanced calcium flux. A similar result was seen when purified splenic B cells from mutant and WT mice were analyzed (Fig. S4, available at ). These data suggested that in the absence of functional Siae, BCR signal strength is markedly enhanced and that this alteration in signal strength is an intrinsic property of mutant B lymphocytes.
###end p 15
###begin p 16
###xml 0 59 0 59 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Accelerated and enhanced BCR signaling in Siae mutant mice.</bold>
###xml 270 271 266 267 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 54 58 <span type="species:ncbi:10090">mice</span>
###xml 91 95 <span type="species:ncbi:10090">mice</span>
###xml 476 480 <span type="species:ncbi:10090">mice</span>
Accelerated and enhanced BCR signaling in Siae mutant mice. Splenocytes from mutant and WT mice were loaded with Indo-1, reacted with 2.4G2, an Fcgamma III/II receptor-blocking antibody, stained with follicular and MZ B cell phenotype markers, and stimulated with F(ab')2 anti-IgM. Populations gated on include newly formed (NF/T1), follicular (FO), and MZ B cells and their precursors (MZ and MZP). Results are representative of three separate experiments and a total of six mice.
###end p 16
###begin title 17
###xml 89 93 85 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
Defective CD22 signaling and hyperacetylation of alpha2-6-linked sialic acid moieties on Siae mutant B cells
###end title 17
###begin p 18
###xml 95 96 91 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 289 293 285 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 293 306 289 294 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;2/&#916;2</sup>
###xml 514 520 502 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 636 640 624 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 640 653 628 633 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;2/&#916;2</sup>
###xml 841 845 821 825 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 845 858 825 830 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;2/&#916;2</sup>
###xml 948 952 920 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 952 965 924 929 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;2/&#916;2</sup>
###xml 1056 1060 1020 1024 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 1060 1073 1024 1029 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;2/&#916;2</sup>
###xml 307 311 <span type="species:ncbi:10090">mice</span>
###xml 654 658 <span type="species:ncbi:10090">mice</span>
###xml 730 734 <span type="species:ncbi:10090">mice</span>
###xml 1074 1078 <span type="species:ncbi:10090">mice</span>
The defect in Siae could result in the increased acetylation of alpha2-6-linked sialic acid on N-glycans in B cells and, thus, attenuate the ability of glycoproteins on B cells to ligate CD22 and generate inhibitory signals. We sought to examine if there was a defect in CD22 signaling in SiaeDelta2/Delta2 mice. After BCR cross-linking, CD22 was isolated by immunoprecipitation, and immunoprecipitates were examined for CD22 tyrosine phosphorylation and for associated SHP-1 using Western blot assays. As seen in Fig. 3 (left, experiment 1; and right, experiment 2), tyrosine phosphorylation of CD22 after BCR signaling was reduced in SiaeDelta2/Delta2 mice in spite of similar levels of surface CD22 expression in WT and mutant mice (Figs. S5 and S6, available at ). Recruitment of SHP-1 by CD22 was clearly impaired after BCR ligation of SiaeDelta2/Delta2 B cells as compared with WT B cells. This result showing diminished SHP-1 recruitment in SiaeDelta2/Delta2 B cells is consistent with the accelerated enhancement in BCR signal strength observed in SiaeDelta2/Delta2 mice.
###end p 18
###begin p 19
###xml 32 45 32 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;2/&#916;2</sup>
###xml 28 45 28 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae<sup>&#916;2/&#916;2</sup></italic>
###xml 0 51 0 43 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Defective CD22 signaling in <italic>Siae<sup>&#916;2/&#916;2</sup></italic> mice.</bold>
###xml 46 50 <span type="species:ncbi:10090">mice</span>
###xml 106 110 <span type="species:ncbi:10090">mice</span>
###xml 143 147 <span type="species:ncbi:10090">mice</span>
Defective CD22 signaling in SiaeDelta2/Delta2 mice. Decreased recruitment of SHP-1 by CD22 in Siae mutant mice. Splenocytes from mutant and WT mice were stimulated via the BCR and immunoprecipitated with antibody to CD22, and Western blots were developed with antibodies to SHP-1, CD22, and phosphotyrosine. Results of two experiments are shown on the top left and the top right. The bottom presents SHP-1/CD22 ratios quantitated by densitometry.
###end p 19
###begin p 20
###xml 83 85 83 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O-</italic>
###xml 131 135 127 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 135 148 131 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;2/&#916;2</sup>
###xml 157 158 145 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 366 368 354 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O-</italic>
###xml 551 553 535 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">28</xref>
###xml 698 699 682 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 784 785 768 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 827 828 811 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 919 920 899 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 949 953 929 933 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 953 966 933 938 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;2/&#916;2</sup>
###xml 1001 1007 973 979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4</xref>
###xml 149 153 <span type="species:ncbi:10090">mice</span>
###xml 456 461 <span type="species:ncbi:9606">human</span>
It remained to be demonstrated whether a defect in Siae would result in enhanced 9-O-acetylation of alpha2-6-linked sialic acid in SiaeDelta2/Delta2 mice. 9-O-acetylation of sialic acid has not been previously observed on B cells, and it is likely that this modification occurs only transiently on WT B lymphocytes. A well established reagent for the detection of 9-O-acetylated alpha2-6-linked sialic acid is a fusion protein containing the Fc portion of human IgG and the influenza C hemagglutinin esterase treated with diisopropyl fluorophosphate (28). Modification of the catalytic serine nucleophile in this fusion protein by diisopropyl fluorophosphate permits the viral protein to bind to 9-O-acetyl sialic acid but not to cleave it. This reagent, designated CHE-FcD, binds to N-linked glycans that are decorated with 9-O-acetylated alpha2-6-linked sialic acid moieties. As predicted, a consistent increase in 9-O-acetylation was detected in SiaeDelta2/Delta2 B cells compared with WT B cells (Fig. 4).
###end p 20
###begin p 21
###xml 12 13 12 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 0 80 0 76 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Increased 9-<italic>O</italic>-acetylation of &#945;2&#8211;6-linked sialic acid in Siae mutant B cells.</bold>
###xml 122 126 <span type="species:ncbi:10090">mice</span>
###xml 245 249 <span type="species:ncbi:10090">mice</span>
Increased 9-O-acetylation of alpha2-6-linked sialic acid in Siae mutant B cells. Splenocytes from 11-wk-old WT and mutant mice were treated with the CHE-FcD reagent and stained with surface phenotype markers. Results are representative of three mice. X axes show log of fluorescence intensity.
###end p 21
###begin p 22
###xml 129 133 129 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 133 146 133 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;2/&#916;2</sup>
###xml 491 493 483 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 494 496 486 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 728 730 720 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 732 734 724 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 147 151 <span type="species:ncbi:10090">mice</span>
###xml 397 401 <span type="species:ncbi:10090">mice</span>
###xml 445 449 <span type="species:ncbi:10090">mice</span>
In keeping with the increased magnitude of BCR signaling, antigen receptor ligation induced enhanced proliferation of B cells in SiaeDelta2/Delta2 mice (Fig. S7, available at ). Thymidine uptake studies uncovered a delayed stimulus strength-dependent inhibition of proliferation (Fig. S8) that might be related to a modest increase in ongoing spontaneous apoptosis of follicular B cells in mutant mice (Fig. S9). Four different CD22-null mutant mice have been described by different groups (13-16), and although enhanced antigen receptor signaling was observed in all four mutants, BCR-induced proliferation was enhanced in some mutants and diminished in others. Enhanced cell death has also been reported in some CD22 mutants (14, 16).
###end p 22
###begin title 23
Siae influences peripheral B cell development
###end title 23
###begin p 24
###xml 166 168 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib31">31</xref>
###xml 185 193 185 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 A</xref>
###xml 269 273 269 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 273 286 273 278 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;2/&#916;2</sup>
###xml 395 397 387 389 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 400 402 392 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 407 409 399 401 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 452 454 444 446 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 457 459 449 451 <sup xmlns:xlink="http://www.w3.org/1999/xlink">lo</sup>
###xml 463 465 455 457 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 503 507 495 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 507 520 499 504 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;2/&#916;2</sup>
###xml 527 535 511 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 B</xref>
###xml 588 592 572 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 592 605 576 581 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;2/&#916;2</sup>
###xml 612 619 588 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table I</xref>
###xml 287 291 <span type="species:ncbi:10090">mice</span>
###xml 521 525 <span type="species:ncbi:10090">mice</span>
###xml 606 610 <span type="species:ncbi:10090">mice</span>
Enhanced BCR signaling in the absence of negative regulators of the BCR such as Aiolos or CD22 has been linked to the relative absence of marginal zone (MZ) B cells (29-31). As seen in Fig. 5 A, immunohistochemistry revealed a marked reduction in splenic MZ B cells in SiaeDelta2/Delta2 mice, although some reduction in follicle size was also apparent. Flow cytometric analysis revealed that IgMhiIgDhi CD21hi MZ B cell precursors (MZP), as well as IgMhiIgDloCD21hi MZ B cells, were markedly reduced in SiaeDelta2/Delta2 mice (Fig. 5 B). An analysis of the absolute numbers of B cells in SiaeDelta2/Delta2 mice (Table I) revealed a striking decrease in MZP and MZ B cells and a more modest reduction in follicular B cells. These results are consistent with the ability of Siae to negatively regulate BCR signaling.
###end p 24
###begin p 25
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 0 102 0 102 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The <italic>Siae</italic> mutation affects the development of MZ and perisinusoidal B cells in a cell-intrinsic manner.</bold>
###xml 164 168 164 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 168 181 168 173 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;2/&#916;2</sup>
###xml 525 529 516 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 529 542 520 525 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;2/&#916;2</sup>
###xml 744 746 727 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib61">61</xref>
###xml 844 848 827 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 848 861 831 836 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;2/&#916;2</sup>
###xml 1208 1210 1183 1185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">32</xref>
###xml 1309 1313 1284 1288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 1313 1326 1288 1293 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;2/&#916;2</sup>
###xml 1555 1559 1522 1526 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 1559 1572 1526 1531 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;2/&#916;2</sup>
###xml 1697 1702 1656 1661 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rag-1</italic>
###xml 1702 1705 1661 1664 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1936 1940 1895 1899 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 1940 1953 1899 1904 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;2/&#916;2</sup>
###xml 2036 2040 1987 1991 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 2040 2053 1991 1996 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;2/&#916;2</sup>
###xml 401 405 <span type="species:ncbi:10090">mice</span>
###xml 543 547 <span type="species:ncbi:10090">mice</span>
###xml 625 629 <span type="species:ncbi:10090">mice</span>
###xml 783 787 <span type="species:ncbi:10090">mice</span>
###xml 862 866 <span type="species:ncbi:10090">mice</span>
###xml 1248 1252 <span type="species:ncbi:10090">mice</span>
###xml 1327 1331 <span type="species:ncbi:10090">mice</span>
###xml 1469 1473 <span type="species:ncbi:10090">mice</span>
###xml 1573 1577 <span type="species:ncbi:10090">mice</span>
###xml 1589 1593 <span type="species:ncbi:10090">mice</span>
###xml 1706 1710 <span type="species:ncbi:10090">mice</span>
###xml 1820 1824 <span type="species:ncbi:10090">mice</span>
###xml 1862 1866 <span type="species:ncbi:10090">mice</span>
###xml 1954 1958 <span type="species:ncbi:10090">mice</span>
###xml 2054 2058 <span type="species:ncbi:10090">mice</span>
###xml 2096 2100 <span type="species:ncbi:10090">mice</span>
The Siae mutation affects the development of MZ and perisinusoidal B cells in a cell-intrinsic manner. (A) Immunohistochemistry reveals a decrease in MZ B cells in SiaeDelta2/Delta2 spleens. B cells were stained with anti-IgM (brown) and metallophilic macrophages with the MOMA-1 antibody (blue). FO, follicular compartment, and MZMM, MZ metallophilic macrophages. Results are representative of three mice per group in the age range of 8-12 wk. Bars, 100 mum. (B) Flow cytometric analyses reveal a reduction in MZ B cells in SiaeDelta2/Delta2 mice. Splenic B cell populations were analyzed by flow cytometry in mutant and WT mice. MZ, MZ B cells, NF, newly formed B cells; FO-I, follicular type I B cells and FO-II, follicular type II B cells (61). Results are representative of >10 mice per group. (C) Perisinusoidal BM B cells are reduced in SiaeDelta2/Delta2 mice as demonstrated by flow cytometry. BM B cell populations were analyzed by flow cytometry. Fractions (Fr.) A-C' represent pro-B and large pre-B cells, Fraction D represents small pre-B cells, Fraction E represents immature B cells, and Fraction F represents recirculating perisinusoidal B cells. The gating strategy was described previously (32). Results are representative of five mice per group. (D) Peritoneal B-1b B cells are increased in SiaeDelta2/Delta2 mice but B-1a B cells are decreased. Flow cytometric analyses were performed on peritoneal cavity B cells. Results are representative of five mice per group. The histogram shows absolute numbers of peritoneal B1 cells in WT and SiaeDelta2/Delta2 mice with three mice per group. Error bars represent SEM. (E) Siae affects B cell development in a B cell-intrinsic manner. Rag-1-/- mice were reconstituted with mutant or WT BM. Spleen and BM B cells were analyzed 7 wk later in the reconstituted mice. Results are representative of three mice per group. (F) Normal T cell development in the thymus and spleen in SiaeDelta2/Delta2 mice. Thymocyte and splenic populations were analyzed by flow cytometry in WT and SiaeDelta2/Delta2 mice. Results are representative of three mice per group.
###end p 25
###begin p 26
Absolute numbers of B cells in spleen
###end p 26
###begin p 27
###xml 87 93 87 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5</xref>
###xml 119 120 119 120 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 122 123 122 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 128 132 <span type="species:ncbi:10090">mice</span>
The various B cell populations (MZ, MZP, NF, FO, and Fractions A-F) are defined in the Fig. 5 legend. *, mean (SD) x 106; n = 3 mice per group.
###end p 27
###begin p 28
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib32">32</xref>
###xml 145 147 145 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib33">33</xref>
###xml 182 185 182 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 176 185 176 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aiolos<sup>&#8722;/&#8722;</sup></italic>
###xml 196 199 196 199 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 192 199 192 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD22<sup>&#8722;/&#8722;</sup></italic>
###xml 214 217 214 217 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 210 217 210 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CD72<sup>&#8722;/&#8722;</sup></italic>
###xml 436 438 436 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 439 441 439 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 443 445 443 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib34">34</xref>
###xml 447 449 447 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib35">35</xref>
###xml 535 539 535 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 539 552 539 544 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;2/&#916;2</sup>
###xml 632 640 624 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 C</xref>
###xml 645 653 637 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl2">Table II</xref>
###xml 746 748 738 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib14">14</xref>
###xml 749 751 741 743 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 803 807 795 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 807 820 799 804 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;2/&#916;2</sup>
###xml 861 863 845 847 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 868 869 852 853 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 873 874 857 858 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 915 917 899 901 <sup xmlns:xlink="http://www.w3.org/1999/xlink">hi</sup>
###xml 921 922 905 906 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 938 942 922 926 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 942 955 926 931 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;2/&#916;2</sup>
###xml 962 970 938 946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 D</xref>
###xml 1017 1019 993 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 1043 1045 1019 1021 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib15">15</xref>
###xml 1067 1069 1043 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 160 164 <span type="species:ncbi:10090">mice</span>
###xml 186 190 <span type="species:ncbi:10090">mice</span>
###xml 200 204 <span type="species:ncbi:10090">mice</span>
###xml 218 222 <span type="species:ncbi:10090">mice</span>
###xml 553 557 <span type="species:ncbi:10090">mice</span>
###xml 740 744 <span type="species:ncbi:10090">mice</span>
###xml 828 832 <span type="species:ncbi:10090">mice</span>
###xml 956 960 <span type="species:ncbi:10090">mice</span>
Follicular B cells occupy two niches: the follicular niche in conventional secondary lymphoid organs and the perisinusoidal niche in the BM (32, 33). In mutant mice, including Aiolos-/- mice, CD22-/- mice, and CD72-/- mice, all of which exhibit enhanced BCR signal strength, there is a selective loss of recirculating follicular phenotype B cells from the perisinusoidal niche even as these cells efficiently seed the follicular niche (14-16, 34, 35). We examined follicular phenotype B cell populations in the perisinusoidal niche in SiaeDelta2/Delta2 mice and noted a marked and selective loss of recirculating B cells in the BM (Fig. 5 C and Table II, fraction F), again paralleling a phenotypic alteration previously noted in CD22-null mice (14-16). We analyzed peritoneal B-1 B cell populations in SiaeDelta2/Delta2 and WT mice and noted an increase in IgMhi CD43+ CD5- B1b B cells but decreased numbers of IgMhi CD5+ B1a B cells in SiaeDelta2/Delta2 mice (Fig. 5 D). The CD22 mutants showed increased B1 cells (13), increased B1a cells (15), or normal numbers (16).
###end p 28
###begin p 29
Absolute numbers of B cells in BM
###end p 29
###begin p 30
###xml 17 18 17 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 20 21 20 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 26 30 <span type="species:ncbi:10090">mice</span>
*, mean (SD) x 106; n = 3 mice per group.
###end p 30
###begin title 31
A lymphocyte-intrinsic defect in Siae contributes to peripheral B cell phenotypes
###end title 31
###begin p 32
###xml 143 146 143 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 138 146 138 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rag-1<sup>&#8722;/&#8722;</sup></italic>
###xml 194 198 194 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 198 211 198 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;2/&#916;2</sup>
###xml 216 220 208 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 220 233 212 217 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;2/&#916;2</sup>
###xml 358 366 342 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 E</xref>
###xml 543 551 527 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 F</xref>
###xml 643 653 627 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl3">Tables III</xref>
###xml 658 660 642 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl4">IV</xref>
###xml 753 755 737 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib36">36</xref>
###xml 775 779 759 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 896 903 880 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ST6GalI</italic>
###xml 1050 1052 1030 1032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">37</xref>
###xml 1054 1056 1034 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib38">38</xref>
###xml 1154 1155 1134 1135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 1266 1267 1246 1247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 1303 1305 1283 1285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib39">39</xref>
###xml 1306 1308 1286 1288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib42">42</xref>
###xml 1437 1438 1417 1418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 1575 1579 1555 1559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 1612 1613 1592 1593 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 1637 1639 1617 1619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib43">43</xref>
###xml 1642 1646 1622 1626 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cmah</italic>
###xml 1668 1677 1648 1657 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cmah/Siae</italic>
###xml 1858 1862 1838 1842 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cmah</italic>
###xml 1962 1964 1942 1944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib44">44</xref>
###xml 1998 2002 1978 1982 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cmah</italic>
###xml 2037 2038 2017 2018 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 2124 2128 2104 2108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cmah</italic>
###xml 2143 2152 2123 2132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cmah/Siae</italic>
###xml 2576 2577 2556 2557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 147 151 <span type="species:ncbi:10090">mice</span>
###xml 263 267 <span type="species:ncbi:10090">mice</span>
###xml 686 690 <span type="species:ncbi:10090">mice</span>
###xml 787 791 <span type="species:ncbi:10090">mice</span>
###xml 909 914 <span type="species:ncbi:10090">mouse</span>
###xml 1059 1065 <span type="species:ncbi:10090">Murine</span>
###xml 1079 1084 <span type="species:ncbi:9606">human</span>
###xml 1214 1219 <span type="species:ncbi:10090">mouse</span>
###xml 1392 1396 <span type="species:ncbi:10090">mice</span>
###xml 1652 1656 <span type="species:ncbi:10090">mice</span>
###xml 1692 1696 <span type="species:ncbi:10090">mice</span>
###xml 1870 1874 <span type="species:ncbi:10090">mice</span>
###xml 2008 2012 <span type="species:ncbi:10090">mice</span>
###xml 2134 2138 <span type="species:ncbi:10090">mice</span>
###xml 2167 2171 <span type="species:ncbi:10090">mice</span>
###xml 2555 2559 <span type="species:ncbi:10090">mice</span>
###xml 2655 2659 <span type="species:ncbi:10090">mice</span>
To determine whether the alteration in peripheral B cell populations reflected a cell-intrinsic defect in Siae function, we reconstituted Rag-1-/- mice with hematopoietic stem cells from WT and SiaeDelta2/Delta2 BM. SiaeDelta2/Delta2 lymphocytes in reconstituted mice exhibited a defect in MZ B cell development and a reduction of perisinusoidal BM B cells (Fig. 5 E), which establishes that these developmental abnormalities represent lymphocyte-intrinsic defects. No gross defect in T cell development was discovered in the absence of Siae (Fig. 5 F), although there was a small decrease in T cell numbers both in the thymus and the spleen (Tables III and IV). Other B cell-deficient mice have been reported to have a mild decrease in T cell numbers (36). The phenotype of Siae mutant mice in which a subtle alteration may have been generated in CD22 ligands is very different from that of the ST6GalI-null mouse, which completely lacks alpha2-6-linked sialic acid and which presents with defects in B cell activation and in thymocyte development (37, 38). Murine CD22, unlike human CD22, has a markedly higher affinity for Neu5Gc (sialic acid with an N-glycolyl moiety in the C5 position; the major form in the mouse) as compared with Neu5Ac (sialic acid with an N-acetyl moiety in the C5 position) (39-42). The enzyme CMP-Neu-5Ac hydroxylase (CMAH) converts CMP-Neu5Ac to CMP-Neu5Gc, and mice lacking this enzyme not only synthesize N-glycans with a subtly different form of sialic acid that binds CD22 poorly but they also exhibit a poorly understood down-regulation of Siae expression and an increase in 9-O-acetylation of Neu5Ac (43). Cmah-null mice as well as Cmah/Siae double mutant mice would therefore be expected to exhibit BCR hyperreactivity, the relative loss of MZ B cells, and a relative loss of perisinusoidal B cells. Indeed, B cells from Cmah mutant mice have been reported to exhibit an enhanced proliferative response to BCR cross-linking (44). We show here that B cells from Cmah-null mice have higher levels of 9-O-acetyated sialic acid as revealed by CHE-FcD binding (Fig. S10, available at ). Both Cmah-null mice and Cmah/Siae double mutant mice present with enhanced BCR activation as measured by the release of intracellular calcium after antigen receptor ligation and, as predicted, present with marked reductions in MZ B cells and perisinusoidal B cells (Figs. S10 and S11). A combination of two changes in the structure of sialic acid that each compromise CD22 binding results in a phenotype that is similar to that seen in mice with enhanced 9-O-acetylation of sialic acid alone but is quite distinct from the phenotype of mice with the complete loss of alpha2-6-linked sialic acid.
###end p 32
###begin p 33
Absolute numbers of T cells in thymus
###end p 33
###begin p 34
###xml 17 18 17 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 20 21 20 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 26 30 <span type="species:ncbi:10090">mice</span>
*, mean (SD) x 106; n = 3 mice per group.
###end p 34
###begin p 35
Absolute numbers of T cells in spleen
###end p 35
###begin p 36
###xml 17 18 17 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 20 21 20 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 26 30 <span type="species:ncbi:10090">mice</span>
*, mean (SD) x 106; n = 3 mice per group.
###end p 36
###begin title 37
###xml 12 16 <span type="species:ncbi:10090">mice</span>
Siae mutant mice exhibit spontaneous increases in class-switched immunoglobulins and autoantibodies
###end title 37
###begin p 38
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 32 45 32 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;2/&#916;2</sup>
###xml 403 407 395 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 407 420 399 404 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;2/&#916;2</sup>
###xml 512 516 496 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 556 560 540 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 560 573 544 549 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;2/&#916;2</sup>
###xml 685 687 661 663 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2b</sub>
###xml 689 697 665 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 A</xref>
###xml 811 819 787 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6 B</xref>
###xml 884 899 860 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6, C and D</xref>
###xml 1063 1065 1039 1041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib45">45</xref>
###xml 46 50 <span type="species:ncbi:10090">mice</span>
###xml 317 321 <span type="species:ncbi:10090">mice</span>
###xml 421 425 <span type="species:ncbi:10090">mice</span>
###xml 524 528 <span type="species:ncbi:10090">mice</span>
###xml 574 578 <span type="species:ncbi:10090">mice</span>
###xml 828 832 <span type="species:ncbi:10090">mice</span>
###xml 943 947 <span type="species:ncbi:10090">mice</span>
###xml 1033 1037 <span type="species:ncbi:10090">mice</span>
Many phenotypic features of SiaeDelta2/Delta2 mice resemble those seen in the absence of CD22. These include enhanced BCR signaling, the loss of MZ B cells, and a reduction in perisinusoidal B cells. Subtle alterations in responses to synthetic T-dependent and T-independent antigens have been described in CD22-null mice, and an altered spectrum of responsiveness to similar antigens was also noted in SiaeDelta2/Delta2 mice. Immunization with DNP-KLH resulted in diminished IgG2a, IgG2b, and IgG3 responses in Siae mutant mice (Fig. S12, available at ). SiaeDelta2/Delta2 mice spontaneously developed high levels of certain class-switched serum immunoglobulins, including IgE and IgG2b (Fig. 6 A), as well as high titers of antinuclear antibodies and circulating immune complexes as early as at 20 wk of age (Fig. 6 B). These mice also develop an immune complex glomerulonephritis (Fig. 6, C and D). Anti-DNA antibodies develop in CD22-null mice after 9 mo of age, but glomerular immune complex deposits were not observed in these mice on a C57BL/6 background (45).
###end p 38
###begin p 39
###xml 0 71 0 71 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Increased serum immunoglobulins and autoantibodies in Siae mutant mice.</bold>
###xml 334 338 334 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 338 351 338 343 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;2/&#916;2</sup>
###xml 1186 1190 1177 1181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 1190 1203 1181 1186 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;2/&#916;2</sup>
###xml 1339 1343 1322 1326 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 1343 1356 1326 1331 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;2/&#916;2</sup>
###xml 66 70 <span type="species:ncbi:10090">mice</span>
###xml 143 147 <span type="species:ncbi:10090">mice</span>
###xml 236 241 <span type="species:ncbi:10090">mouse</span>
###xml 352 356 <span type="species:ncbi:10090">mice</span>
###xml 470 475 <span type="species:ncbi:10090">mouse</span>
###xml 521 525 <span type="species:ncbi:10090">mice</span>
###xml 633 637 <span type="species:ncbi:10090">mice</span>
###xml 655 659 <span type="species:ncbi:10090">mice</span>
###xml 766 770 <span type="species:ncbi:10090">mice</span>
###xml 899 903 <span type="species:ncbi:10090">mice</span>
###xml 1109 1113 <span type="species:ncbi:10090">mice</span>
###xml 1204 1208 <span type="species:ncbi:10090">mice</span>
###xml 1357 1361 <span type="species:ncbi:10090">mice</span>
###xml 1454 1458 <span type="species:ncbi:10090">mice</span>
Increased serum immunoglobulins and autoantibodies in Siae mutant mice. (A) Serum immunoglobulins of specific isotypes are increased in mutant mice. Immunoglobulin isotypes were quantitated by ELISA. Each data point represents a single mouse. Horizontal bars represent the mean. (B) Increased levels of autoantibodies in the serum of SiaeDelta2/Delta2 mice. ELISA was used to estimate the levels of various autoimmune antibodies in serum. Each data point represents one mouse. Horizontal bars represent the mean. Ages of mice in A and B ranged from 20-60 wk. The results presented A and B and in C and D are all from the same set of mice. (C) Siae mutant mice show histological features of glomerulonephritis. Paraffin-embedded sections of kidney from mutant and WT mice were stained with hematoxylin and eosin (top) and with periodic acid Schiff (PAS) reagent (bottom). The glomeruli of the mutant mice (top right) show mesangial hypercellularity and expansion caused by periodic acid Schiff-positive deposits (bottom). The magnification is marked on each image. Bars, 100 mum. Results are representative of mice described in A and B. (D) IgG immune complex deposition in glomeruli of SiaeDelta2/Delta2 mice. Immunofluorescence studies on frozen sections of kidney reveal enlarged glomeruli with IgG-positive deposits in the mesangium in SiaeDelta2/Delta2 mice. The magnification is marked on each image. Bars, 100 mum. These sections are from the same mice as those shown in C.
###end p 39
###begin p 40
###xml 85 87 85 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib45">45</xref>
###xml 211 213 211 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib46">46</xref>
###xml 231 233 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 234 236 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
###xml 274 276 274 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 512 514 512 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib46">46</xref>
###xml 577 583 577 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7</xref>
###xml 225 229 <span type="species:ncbi:10090">mice</span>
###xml 268 272 <span type="species:ncbi:10090">mice</span>
It has been suggested that CD22 may function as an enforcer of peripheral tolerance (45), and a possible role for CD22 in setting signaling thresholds in the context of tolerance has been previously postulated (46). Lyn-null mice (17-19), as well as conditional SHP-1 mice (21), develop a lupuslike phenotype, supporting the notion that CD22, possibly other Siglecs, SHP-1, and Lyn are part of an inhibitory axis setting higher thresholds for B cell activation by self-antigens as well as by exogenous antigens (46). Siae may be an important component of this inhibitory axis (Fig. 7).
###end p 40
###begin p 41
###xml 0 119 0 119 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Siae regulates the availability of Siglec ligands on B cells and thus controls B cell antigen receptor signal strength.</bold>
###xml 260 261 260 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 279 280 279 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
Siae regulates the availability of Siglec ligands on B cells and thus controls B cell antigen receptor signal strength. In mature B cells, BCR signaling thresholds are set by inhibitory molecules such as CD22. Sialic acid-containing ligands for Siglecs can be O-acetylated by an O-acetyltransferase in the Golgi. Acetyl moieties may be subsequently removed by Siae in an exocytic compartment or on the cell surface. In the absence of functional Siae, BCR signaling is no longer constrained by CD22 or other Siglecs on B cells.
###end p 41
###begin title 42
DISCUSSION
###end title 42
###begin p 43
###xml 66 70 66 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 130 132 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 133 135 133 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 30 34 <span type="species:ncbi:10090">mice</span>
###xml 124 128 <span type="species:ncbi:10090">mice</span>
In this article, we show that mice with an engineered deletion in Siae phenocopy many of the alterations seen in CD22 -null mice (13-16). These common features include an enhancement of BCR-induced release of calcium from internal stores, the loss of MZ B cells, a reduction in BM perisinusoidal B cells, alterations in B cell proliferation that are dependent on the degree and duration of BCR cross-linking, some increase in follicular B cell apoptosis, and the spontaneous development of antinuclear antibodies.
###end p 43
###begin p 44
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 95 96 91 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 118 119 114 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 672 674 664 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib47">47</xref>
###xml 862 864 854 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 866 868 858 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib48">48</xref>
###xml 1131 1133 1123 1125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 1376 1378 1368 1370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib49">49</xref>
###xml 40 44 <span type="species:ncbi:10090">mice</span>
###xml 460 464 <span type="species:ncbi:10090">mice</span>
###xml 879 883 <span type="species:ncbi:10090">mice</span>
###xml 1029 1033 <span type="species:ncbi:10090">mice</span>
###xml 1105 1110 <span type="species:ncbi:10090">mouse</span>
###xml 1329 1333 <span type="species:ncbi:10090">mice</span>
Our results suggest that in Siae mutant mice, terminal alpha2-6-linked sialic acid moieties on N-linked glycans are 9-O-acetylated and, as a result, CD22 cannot readily inhibit BCR signaling. Although these results imply that ligation of CD22 by alpha2-6 sialic acid-containing ligands contributes to inhibitory signaling, the precise role that sialoglyconjugates play in the function of CD22 remains to be determined with certainty. The phenotypes of CD22 KO mice clearly suggest that a major in vivo function of this Siglec is to attenuate BCR signaling, but other studies have suggested that CD22 may potentially contribute to both inhibitory and activating functions (47). Mutating or blocking the sialic acid binding site of CD22 in a cell line context led to a loss of CD22 inhibitory signaling as indicated by an enhanced calcium flux after BCR ligation (11, 48). Knockin mice harboring an identical mutation in the sialic acid binding site of CD22 exhibited some, but not all, of the phenotypic changes seen in CD22 null mice. Strikingly, an enhanced calcium flux was not observed in this knockin mouse after BCR ligation (22). Background-dependent modifier genes do contribute to differences seen in CD22-dependent phenotypes in KO and knockin animals, and there is growing evidence from SNP genotyping that even inbred mice strains are heterogenous at several loci (49). Nevertheless, no satisfactory explanation can be provided at present for the discrepant results of site directed mutagenesis-based studies of CD22 function.
###end p 44
###begin p 45
###xml 133 134 129 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 410 412 406 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib37">37</xref>
###xml 519 526 511 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ST6GalI</italic>
###xml 605 607 597 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib50">50</xref>
###xml 767 769 759 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 897 904 889 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ST6GalI</italic>
###xml 1025 1027 1017 1019 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib38">38</xref>
###xml 160 164 <span type="species:ncbi:10090">mice</span>
###xml 291 295 <span type="species:ncbi:10090">mice</span>
###xml 532 537 <span type="species:ncbi:10090">mouse</span>
###xml 912 916 <span type="species:ncbi:10090">mice</span>
###xml 981 985 <span type="species:ncbi:10090">mice</span>
ST6GalI is the sialyl transferase that transfers sialic acid in an alpha2-6-linked form from CMP-Sia to the preterminal galactose on N-glycans in the Golgi. In mice lacking ST6GalI, the absence of ligands for CD22 might have been expected to result in enhanced BCR signaling. Instead, these mice exhibit a gross defect in B cell signaling after ligation of the BCR and of other mitogenic receptors in B cells (37). One interpretation provided for these data is that in the absence of alpha2-6-linked sialic acid in the ST6GalI-null mouse, CD22 fails to multimerize and cannot be sequestered from the BCR (50). It is possible that in the absence of ST6GalI, inhibition of the BCR by CD22 is enhanced because of an abnormal facilitation of CD22 and IgM colocalization (23). However, the basis for this enhanced colocalization is not known, the reason for the relatively broad defect in signaling in ST6GalI mutant mice is not entirely clear, and is it not fully understood why these mice have defects in thymocyte development (38).
###end p 45
###begin p 46
###xml 108 110 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 112 114 112 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib51">51</xref>
###xml 293 296 293 296 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 304 307 304 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 289 307 289 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cd22<sup>&#8722;/&#8722;</sup>/ST6GalI<sup>&#8722;/&#8722;</sup></italic>
###xml 486 489 486 489 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 482 489 482 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cd22<sup>&#8722;/&#8722;</sup></italic>
###xml 1038 1039 1034 1035 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 1083 1085 1079 1081 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib52">52</xref>
###xml 1230 1231 1226 1227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 1279 1283 1275 1279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 1331 1332 1327 1328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 1367 1371 1363 1367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cmah</italic>
###xml 1391 1400 1387 1396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cmah-Siae</italic>
###xml 1510 1517 1506 1513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ST6Gal1</italic>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 102 106 <span type="species:ncbi:10090">mice</span>
###xml 308 312 <span type="species:ncbi:10090">mice</span>
###xml 442 446 <span type="species:ncbi:10090">mice</span>
###xml 1262 1266 <span type="species:ncbi:10090">mice</span>
###xml 1377 1382 <span type="species:ncbi:10090">mouse</span>
###xml 1415 1420 <span type="species:ncbi:10090">mouse</span>
###xml 1521 1526 <span type="species:ncbi:10090">mouse</span>
Mice that lack both CD22 and ST6GalI exhibit enhanced BCR signaling similar to that seen in CD22-null mice (23, 51). Although these data have been interpreted to indicate a restoration in the absence of CD22 of BCR signaling that was diminished in the absence of ST6Gal I, both studies on cd22-/-/ST6GalI-/- mice do not actually show a restoration of BCR signaling to WT levels but demonstrate that BCR signaling is enhanced in double mutant mice to levels similar to those seen in cd22-/- B cells. The loss of CD22 may be considered to be dominant. These data are therefore compatible with the possibility that CD22 can provide inhibitory signals constitutively, presumably by providing ITIM tyrosines as a potential substrate for phosphorylation by Lyn and other Src family kinases. Nevertheless, CD22 might provide optimal inhibitory signals only in the presence of its sialoglycoconjugate ligands. The total absence of alpha2-6-linked sialic acid may represent a relatively drastic alteration that could result in aberrant capping of N-acetyllactosamine termini of many glycans (52) and might affect B cell function adversely in poorly understood ways. A subtle alteration of the structure of CD22 ligands, such as enhanced 9-O-acetylation of sialic acid in mice with mutant Siae, or the combined loss of Neu5Gc and enhanced 9-O-acetylation of sialic acid in the Cmah-null mouse and the Cmah-Siae double mutant mouse both appear to provide somewhat different insights compared with those obtained from the ST6Gal1 KO mouse harboring a more global alteration in CD22 ligand structure.
###end p 46
###begin p 47
###xml 15 19 15 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 100 104 100 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cd22</italic>
###xml 104 107 104 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 291 293 291 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib45">45</xref>
###xml 549 553 549 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 950 952 950 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib53">53</xref>
###xml 1239 1243 1239 1243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cmah</italic>
###xml 27 31 <span type="species:ncbi:10090">mice</span>
###xml 108 112 <span type="species:ncbi:10090">mice</span>
###xml 227 231 <span type="species:ncbi:10090">mice</span>
###xml 561 565 <span type="species:ncbi:10090">mice</span>
###xml 604 608 <span type="species:ncbi:10090">mice</span>
###xml 631 635 <span type="species:ncbi:10090">mice</span>
###xml 893 899 <span type="species:ncbi:10090">murine</span>
###xml 992 996 <span type="species:ncbi:10090">mice</span>
In contrast to Siae mutant mice that have detectable anti-DNA antibodies when they are 5 mo of age, cd22-/- mice, also on a C57BL/6 background, develop anti-DNA antibodies only when they are at least 9 mo old, and these latter mice do not develop kidney deposits of antibody and complement (45). Collectively, the spontaneous secretion of increased levels of class switched immunoglobulins and antichromatin antibodies, the accumulation of glomerular immune complex deposits, and the apparent activation-dependent attrition of follicular B cells in Siae mutant mice suggest a stronger phenotype in these mice than that observed in mice lacking CD22. These data suggest indirectly that Siae might not only attenuate CD22 function but may also possibly regulate an additional Siglec or Siglecs in B cells, although direct evidence for such a hypothesis is lacking. A second inhibitory Siglec in murine B cells, Siglec G, has been previously described (53). However, although Siglec G-deficient mice exhibit a marked increase in B-1a B cells, IgG autoantibodies are not increased. It remains to be determined whether this or any other Siglec, other than CD22, is regulated by Siae. It also remains to be determined if an engineered defect in Cmah leads to an autoimmune state.
###end p 47
###begin p 48
###xml 98 100 98 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib46">46</xref>
###xml 166 170 166 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 682 686 682 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cd22</italic>
###xml 750 752 750 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib46">46</xref>
###xml 754 756 754 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib54">54</xref>
###xml 834 836 834 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib45">45</xref>
###xml 876 878 876 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib46">46</xref>
###xml 2464 2468 2464 2468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 139 143 <span type="species:ncbi:10090">mice</span>
###xml 178 182 <span type="species:ncbi:10090">mice</span>
###xml 661 676 <span type="species:ncbi:10090">transgenic mice</span>
###xml 2017 2022 <span type="species:ncbi:9606">human</span>
###xml 2476 2480 <span type="species:ncbi:10090">mice</span>
###xml 2557 2561 <span type="species:ncbi:10090">mice</span>
It has been previously suggested that CD22, Lyn, and SHP-1 set a threshold for B cell activation (46). The enhanced BCR signaling noted in mice that lack CD22 and in Siae mutant mice suggests that loss of tolerance may result from a mechanism that is distinct from models invoking clonal deletion, receptor editing, and anergy, all of which might be presumed to be enhanced, not abrogated, by an increase in BCR signal strength in B cells. These well established mechanisms of tolerance have been studied extensively using transgenic and knockin models that use relatively high-affinity BCRs for model self-antigens. The analysis of anti-HEL-soluble HEL double transgenic mice in a cd22-null background did not result in a break in tolerance to HEL (46, 54). We expand here on a suggestion originally made by Neuberger and coworkers (45) and also discussed by Cornall et al. (46) that CD22, and possibly other Siglecs, might set thresholds for the activation of B cells in the periphery. Weakly self-reactive B cells may not be activated by self-antigens because CD22 helps set an activation threshold in the periphery. If the strength of activation of B cells by self-antigens were to cross a threshold, the processing and presentation of self-antigens could be facilitated, and the unwanted entry of relatively weakly self-reactive B cells into the germinal center reaction might also occur. There are many potential ways in which, during an infection, a self-structure may be physically complexed with a foreign protein. In a viral infection, for instance, host chromatin may contain proteins of viral origin bound to host antigens including host nucleic acids. If the BCR threshold signaling is not set high enough (because of defects in CD22 or Siae for instance), self-antigens might not only activate weakly self-reactive B cells but may also deliver physically linked foreign proteins to endosomes in B cells, thus permitting the receipt of T cell help for somatic mutation. It is perhaps significant that in human autoimmune diseases in which antibodies are known to be relevant, pathogenic autoantibodies tend to be somatically mutated and class switched. Siglecs, assisted by Siae, presumably play a key role in keeping weakly self-reactive B cells quiescent. It is clear that analyses of responses to one specific T cell-dependent synthetic immunogen are not apparently consonant with the spontaneous immunoglobulin and autoantibody levels observed in Siae mutant mice, and there is a need for more detailed immunization studies in these mutant mice and in controls.
###end p 48
###begin p 49
###xml 65 66 65 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 168 169 168 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 377 378 377 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 409 411 409 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib55">55</xref>
###xml 523 524 523 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 624 625 624 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 820 824 820 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SIAE</italic>
###xml 952 956 952 956 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SIAE</italic>
###xml 833 838 <span type="species:ncbi:9606">human</span>
###xml 853 861 <span type="species:ncbi:9606">patients</span>
Elucidating the full complexity of the biological functions of 9-O-acetylation of sialic acid will require the analysis of a mutant organism that lacks the sialic acid O-acetyl transferase in the Golgi complex that can transfer an acetyl moiety from acetyl CoA to the 7-OH or 9-OH position of terminal sialic acid residue on glycoconjugates. Although more than one sialic acid O-acetyl transferase may exist (55), to date no such O-acetyl transferase has been molecularly identified. Our data indicate that modulation of 9-O-acetylation of sialic acid, a modification which was first described more than half a century ago (1), regulates inhibitory signaling in B lymphocytes and participates in the maintenance of immunological tolerance. Furthermore, our ongoing unpublished studies involving deep resequencing of the SIAE gene in human controls, and patients with autoimmunity have revealed a strong association of rare loss-of-function variants of SIAE with autoimmune disease, suggesting that the regulatory function of Siae is not restricted to rodents (unpublished data).
###end p 49
###begin p 50
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 93 95 93 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">26</xref>
Siae was identified over a decade ago as a gene that is regulated during B cell development (26). We have now shown that this enzyme regulates the cell surface acetylation of sialic acid. It remains to be determined where exactly in B cells Siae is located and whether the expression and catalytic activity of this enzyme is regulated during antigen-mediated B cell activation.
###end p 50
###begin title 51
MATERIALS AND METHODS
###end title 51
###begin title 52
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice.
###end title 52
###begin p 53
###xml 33 37 33 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rag1</italic>
###xml 38 42 <span type="species:ncbi:10090">mice</span>
8-12-wk-old C57BL/6 and B6.129S7-Rag1 mice (The Jackson Laboratory) were used in this study. Animal procedures were approved by the subcommittees on research animal care at Massachussetts General Hospital and at the University of California, San Diego.
###end p 53
###begin title 54
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 29 42 29 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;2/&#916;2</sup>
###xml 43 47 <span type="species:ncbi:10090">mice</span>
Generation of homozygous SiaeDelta2/Delta2 mice.
###end title 54
###begin p 55
###xml 10 14 10 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 257 259 257 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib56">56</xref>
###xml 801 805 798 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 1208 1212 1205 1209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 1212 1225 1209 1214 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;2/&#916;2</sup>
###xml 957 961 <span type="species:ncbi:10090">mice</span>
###xml 1147 1151 <span type="species:ncbi:10090">mice</span>
###xml 1226 1230 <span type="species:ncbi:10090">mice</span>
###xml 1514 1518 <span type="species:ncbi:10090">mice</span>
Exon 2 of Siae encoding the N terminus of the Lse form of Siae was deleted. The Siae targeting vector was assembled from a 129/Sv genomic clone by inserting the 0.7-kb BamHI-XbaI fragment, containing exon 2 of Siae, into the BamHI site of the pflox vector (56). Adjacent 129/Sv Siae genomic sequences were added by subcloning the 1.5-kb XbaI-NheI fragment into the XhoI site and the BamHI-BamHI 9-kb fragment into the SalI site of pflox. 10 mug of NotI-linearized targeting vector was electroporated into 150 mug/ml R1 ES cells and G418-resistant transfectants, which was positive by PCR for homologous recombination and retaining all three loxP sites, and was transfected with the pCreHygro expression vector. After 4 d of 2-muM gancyclovir selection, subclones were isolated and those harboring the Siae-floxed allele were detected by Southern blotting with BamHI-SpeI genomic digestion and a loxP probe. Two ES cell clones were used to generate chimeric mice in C57BL/6 host embryos. Offspring were genotyped by Southern blotting with BamHI-SpeI tail DNA hybridized to the 3' probe (3S0.6). Heterozygous offspring were mated to C57BL/6 ZP3-Cre mice. Female offspring were then mated to produce homozygous SiaeDelta2/Delta2 mice. PCR primers used for genotyping were as follows: PS-LseG-16, 5'-TTTAGGAGCAAGGGGTTGGCCAAGA-3'; PS-LseG-B, 5'-GGTTTCCTGACCTTGGCACAAGGT-3'; and LOX-R, 5'-CGGTACCCGGGGATCAATTCGAG-3'. PS-LseG-16 and PS-LseG-B yield the 420-bp WT band and PS-LseG-16 and LOX-R the 340-bp mutant band. The mice used in these studies were backcrossed into the C57BL/6 background for 10 generations and then maintained by intercrossing.
###end p 55
###begin title 56
Antibodies, staining, and flow cytometry.
###end title 56
###begin p 57
###xml 118 120 118 120 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2a</sub>
###xml 157 159 153 155 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2a</sub>
###xml 202 204 194 196 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2b</sub>
###xml 250 251 242 243 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 290 292 278 280 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2a</sub>
###xml 332 334 316 318 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2b</sub>
###xml 391 393 371 373 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2b</sub>
###xml 438 440 414 416 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2a</sub>
###xml 539 541 511 513 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2a</sub>
###xml 14 20 <span type="species:ncbi:10090">murine</span>
###xml 111 114 <span type="species:ncbi:10116">rat</span>
###xml 150 153 <span type="species:ncbi:10116">rat</span>
###xml 195 198 <span type="species:ncbi:10116">rat</span>
###xml 233 238 <span type="species:ncbi:10090">mouse</span>
###xml 283 286 <span type="species:ncbi:10116">rat</span>
###xml 325 328 <span type="species:ncbi:10116">rat</span>
###xml 384 387 <span type="species:ncbi:10116">rat</span>
###xml 431 434 <span type="species:ncbi:10116">rat</span>
###xml 496 499 <span type="species:ncbi:10116">rat</span>
###xml 532 535 <span type="species:ncbi:10116">rat</span>
The following murine monoclonal antibody conjugates were used: Allophycocyanin (APC)-RA3-6B2 (anti-CD45R/B220, rat IgG2a, kappa), FITC-S7 (anti-CD43, rat IgG2a, kappa), FITC-7G6 (anti-CD21/CD35, rat IgG2b), FITC-Cy34.1 (anti-CD22.2, mouse [DBA/1] IgG1, kappa), APC-53-7.3 (anti-CD5, rat IgG2a, kappa), APC-M1/70 (anti-CD11b, rat IgG2b, kappa), r-phycoerythrin (R-PE)-GK1.5 (anti-CD4, rat IgG2b, kappa), and FITC-53-6.7 (anti-CD8a, rat IgG2a,kappa; all from BD); and APC and R-PE-1B4B1 (anti-IgM, rat IgG), and R-PE-11-26 (anti-IgD, rat IgG2a, kappa; SouthernBiotech).
###end p 57
###begin p 58
###xml 289 290 289 290 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 382 384 377 379 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2b</sub>
###xml 375 378 <span type="species:ncbi:10116">rat</span>
Single cell suspensions were made from spleen, BM (one femur and tibia), thymus, and peritoneal washings using standard methodology. Red cells were lysed with 2 ml ACK lysing buffer (Cambrex). The lysis buffer was neutralized by adding 10 ml PBS and 0.2% BSA (PBA). Before staining, 1 x 106 cells were reacted with 2.5 mug of 2.4G2 (anti-CD16/CD32 [Fcgamma III/II receptor], rat IgG2b, kappa; BD). Surface staining was performed using appropriate dilutions of antibodies in 12 x 75-mm round-bottom polystyrene tubes in a volume of 200 mul for 30 min in the dark at 4degreesC.
###end p 58
###begin p 59
###xml 64 66 64 66 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib57">57</xref>
###xml 346 347 346 347 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4</sup>
###xml 417 419 417 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib33">33</xref>
Flow cytometric analysis was performed as previously described (57) on a dual laser FC500 (Beckman Coulter), a MoFlo (Dako), and a FACSAria (BD). Unstained cells were used to set voltage and single color positive controls were used for electronic compensation. Viable cells were determined by forward and side scatter characteristics and 3-5 x 104 gated events were collected. Gates were set as previously described (33). Processed samples were analyzed using RXP (Beckman Coulter), and FloJo v8.8 (Tree Star, Inc.) analysis software.
###end p 59
###begin title 60
###xml 62 66 <span type="species:ncbi:10090">mice</span>
Reconstitution of the lymphoid compartment in Rag-1-deficient mice.
###end title 60
###begin p 61
###xml 5 8 5 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rag-1<sup>&#8722;/&#8722;</sup></italic>
###xml 71 72 71 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 9 13 <span type="species:ncbi:10090">mice</span>
Rag-1-/- mice were irradiated with 7.5 Gy and reconstituted with 5 x 106 WT or mutant adult BM cells via tail vein injection. Reconstitution of the BM and spleen was assessed 7 wk later by flow cytometry.
###end p 61
###begin title 62
###xml 15 16 15 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
Detection of 9-O-acetylated sialic acid on splenocytes.
###end title 62
###begin p 63
###xml 136 137 136 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 194 195 194 195 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 284 286 284 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">28</xref>
###xml 288 290 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib58">58</xref>
###xml 363 364 363 364 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 572 573 563 564 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 886 887 866 867 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 926 928 906 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">28</xref>
###xml 185 190 <span type="species:ncbi:9606">human</span>
###xml 365 369 <span type="species:ncbi:9925">goat</span>
###xml 375 380 <span type="species:ncbi:9606">human</span>
The CHE-FcD probe, a fusion protein composed of the extracellular domains of the influenza C hemagglutinin esterase (CHE) which binds 9-O-acetylated sialic acids, and the Fc portion of human IgG1(Fc), treated with diisopropylfluorophosphate (D) was generated as previously described (28, 58). The chimeric CHE Fc-D protein was precomplexed with Cy5 or FITC-F(ab')2 goat anti-human IgG (Jackson ImmunoResearch Laboratories; 1 mul of a 1:10 dilution of CHE-FcD in PBA with 2 mul of the secondary antibody in a total volume of 50 mul PBA) for 2 h at 4degreesC in the dark. 106 cells in 50 mul PBA were preincubated for 45 min at 37degreesC, added to the precomplex, and incubated on ice for an additional 1.5 h. The cells were washed once, reacted with 2.4G2, an Fcgamma III/II receptor-blocking antibody, and surface stained as described earlier. Staining of acetylated sialic acid on CD4+ T cells served as a positive control (28).
###end p 63
###begin title 64
BCR cross-linking and accumulation of cytosolic calcium.
###end title 64
###begin p 65
###xml 73 74 73 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 1273 1274 1209 1210 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
In brief, Indo-1 AM (acetoxymethyl ester; Invitrogen) was added to 3 x 106 splenocytes in 500 mul HBSS (Invitrogen) and 10% FCS (HBSS-10). The final concentration of Indo-1 was 1 muM. The cells were incubated in a 37degreesC water bath for 30 min, held at room temperature for 5 min, and washed with HBSS containing 2 mM Hepes buffer and no serum (HBSH-0). All manipulations including the incubation were in the dark. Cells were then reacted with 2.4G2, an Fcgamma III/II receptor-blocking antibody, surface stained as described earlier, and washed with HBSH-0, all in the dark at 4degreesC. The cells were resuspended in the residual volume and an additional 50 mul HBSH-0 was added to make a total volume of approximately150 mul. The cells were then split into three 50-mul aliquots and the volume made up to 100 mul with HBSH-0. The cells were held in the dark at 4degreesC before analysis. Before calcium flux measurements, the cells were filtered and incubated at RT for 10 min. The cells were warmed to 37degreesC in a heat block for 6 min and placed in the flow cytometer in a chamber maintained at 37degreesC. After a flow rate of approximately500 cells/s was established, acquisition was begun to record a 30-s baseline. After addition of stimulatory antibody (Fab2 fragments of anti-IgM), acquisition was continued for another 180 s with the cells at 37degreesC. Between samples, distilled water was run at a high flow rate for 2 min to flush the lines. The flow cytometer used was a FACS Vantage SE (BD) operating with a laser (Innova Enterprise Model 621; Coherent, Inc.).
###end p 65
###begin title 66
Serum immunoglobulins and autoantibodies.
###end title 66
###begin p 67
Total serum immunoglobulins of various isotypes were analyzed using an ELISA approach (Alpha Diagnostic International, San Antonio, TX). ELISA was also used to quantify serum autoantibodies (anti-dsDNA, anti-ssDNA, anti-histone, anti-Sm) and circulating immune complexes (all from Alpha Diagnostic).
###end p 67
###begin title 68
Immunofluorescence staining, immunohistochemistry and histological staining.
###end title 68
###begin p 69
###xml 58 60 58 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib59">59</xref>
###xml 223 224 223 224 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 562 564 561 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib60">60</xref>
###xml 148 152 <span type="species:ncbi:9925">goat</span>
###xml 225 229 <span type="species:ncbi:9925">goat</span>
###xml 235 240 <span type="species:ncbi:10090">mouse</span>
###xml 317 321 <span type="species:ncbi:9925">goat</span>
Immunofluorescence was performed as previously described (59) with some modifications. Sections for immunofluorescence were blocked with 20% normal goat serum in 1% BSA/PBS for 20 min and stained with FITC-AffiniPure F(ab')2 goat anti-mouse IgG (H + L; Jackson ImmunoResearch Laboratories) diluted 1:200 in 5% normal goat serum/1% BSA/PBS for 15 min in the dark at room temperature. After rinsing three times in PBS for 5' each, sections were mounted using 25 mul of Vectashield (Vector Laboratories). Immunohistochemistry was performed as described previously (60). Paraffin sections were stained with hematoxylin and eosin and the periodic acid Schiff reagent using standard methods.
###end p 69
###begin title 70
Immunoprecipitation and Western blot analysis.
###end title 70
###begin p 71
###xml 31 33 31 33 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 77 78 77 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 114 115 114 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5</sup>
###xml 79 85 <span type="species:ncbi:10090">murine</span>
###xml 242 248 <span type="species:ncbi:9986">rabbit</span>
###xml 488 494 <span type="species:ncbi:9986">rabbit</span>
The method used by Poe et al. (22) was adhered to with some modifications. 107 murine splenocytes or sorted 5 x 105 B cells were lysed before and after BCR ligation using 1% NP40 in PBS. Lysates were immunoprecipitated using anti-CD22 (CD-22 rabbit IgG; Epitomics, Inc.) and protein A Sepharose, and after separation on an SDS/polyacrylamide gel and Western transfer, membranes were probed with antibodies to CD22, SHP-1, and phosphotyrosine (anti-CD22.2, clone Lyb-8.2 [BD]; anti-SHP1/2 rabbit polyclonal IgG, and antiphosphotyrosine, clone 4G10 [Millipore]). Relative expression of CD22 and SHP-1 was quantified using Quantity One software (Bio-Rad Laboratories).
###end p 71
###begin title 72
Online supplemental material.
###end title 72
###begin p 73
###xml 234 238 234 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 380 384 380 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 469 473 469 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 473 486 473 478 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;2/&#916;2</sup>
###xml 873 877 865 869 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cmah</italic>
###xml 973 982 965 974 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae/Cmah</italic>
###xml 1102 1106 1094 1098 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Siae</italic>
###xml 254 258 <span type="species:ncbi:10090">mice</span>
###xml 392 396 <span type="species:ncbi:10090">mice</span>
###xml 487 491 <span type="species:ncbi:10090">mice</span>
###xml 522 526 <span type="species:ncbi:10090">mice</span>
###xml 883 888 <span type="species:ncbi:10090">mouse</span>
###xml 997 1001 <span type="species:ncbi:10090">mice</span>
###xml 1121 1125 <span type="species:ncbi:10090">mice</span>
Fig. S1 shows that Siae is secreted from stably transfected U2OS cells. Fig. S2 shows that Siae is expressed on the surface of transfected U2OS cells and is also partially present in lysosomes. Fig. S3 shows the presence of truncated Siae mRNA in mutant mice as revealed by RT-PCR. Fig. S4 shows accelerated and enhanced BCR-induced calcium release in purified B lymphocytes from Siae mutant mice. Figs. S5 and S6 show that surface expression of CD22 on splenocytes in SiaeDelta2/Delta2 mice is unaltered compared with WT mice. Fig. S7 shows that Siae mutant splenocytes proliferate more than WT B cells. Fig. S8 shows a stimulus strength-dependent inhibition of B cell proliferation after BCR cross-linking. In Fig. S9, mutant resting B splenocytes show a mild increase in apoptosis. In Fig. S10, peripheral B cell populations and the response to BCR cross-linking of the Cmah-null mouse are depicted, and in Fig. S11, similar studies are presented that were performed on Siae/Cmah double mutant mice. Fig. S12 shows antibody responses to synthetic T cell-dependent and T cell-independent antigens in Siae mutant and WT mice. Online supplemental material is available at .
###end p 73
###begin title 74
Supplementary Material
###end title 74
###begin title 75
[Supplemental Material Index]
###end title 75
###begin p 76
###xml 38 43 <span type="species:ncbi:10090">mouse</span>
We acknowledge initial studies of the mouse phenotype by Dawne Page, Jamey Marth, and Laura Martin. Joanne Yetz-Aldape, Suzan Lazo-Kallanian, and John Daley are thanked for help with flow cytometry. We thank Eveline Schneeberger for advice on renal pathology. We thank Stacey Beganny and Jonathan Foley for help with densitometry, and Emily Forbes and Johnathan Whetstine for help with confocal microscopy.
###end p 76
###begin p 77
These studies were supported by grants from the National Institutes of Health to S. Pillai (AI064930 and AI069458) and A. Varki (GM32373 and P01HL057345).
###end p 77
###begin p 78
The authors have no conflicting financial interests.
###end p 78

